Search Results - "Lekhakula, Arnuparp"
-
1
Clinical and Epidemiological Analyses of Human Pythiosis in Thailand
Published in Clinical infectious diseases (01-09-2006)“…Background. Pythiosis is an emerging and life-threatening infectious disease in humans and animals that is caused by the pathogenic oomycete Pythium…”
Get full text
Journal Article -
2
Prognostic Significance of Serum Proangiogenic Molecules in Patients with De Novo Non-Hodgkin Lymphomas
Published in TheScientificWorld (01-01-2012)“…This study was aimed to assess the clinical significances of the serum VEGF and bFGF in Thai patients with de novo NHL. Serum VEGF and bFGF concentrations were…”
Get full text
Journal Article -
3
Incidence, etiology and bone marrow characteristics of non-chemotherapy-induced agranulocytosis
Published in Hematology (Luxembourg) (01-01-2011)“…Agranulocytosis is a rare but fatal condition. The majority of cases are associated with drugs. However, in-patient incidences and the relationship between…”
Get more information
Journal Article -
4
A randomized controlled trial of thrice-weekly versus thrice-daily oral ferrous fumarate treatment in adult patients with iron-deficiency anemia
Published in Annals of hematology (01-06-2023)“…Iron deficiency anemia (IDA) is a common health problem in developing countries. Many studies have shown that low-dose oral iron could have similar efficacy…”
Get full text
Journal Article -
5
Non-Cryopreserved Peripheral Blood Stem Cell Graft for Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma and Lymphoma Patients
Published in Annals of transplantation (17-01-2023)“…BACKGROUND Hematopoietic stem cell transplantation (HSCT) using cryopreserved grafts is time-consuming, expensive treatment, and may associated with dimethyl…”
Get full text
Journal Article -
6
A Phase II trial of Belinostat (PXD101) in patients with relapsed or refractory peripheral or cutaneous T‐cell lymphoma
Published in British journal of haematology (01-03-2015)“…Summary Belinostat is a pan‐histone deacetylase inhibitor with antitumour and anti‐angiogenic properties. An open label, multicentre study was conducted in…”
Get full text
Journal Article -
7
-
8
-
9
Treatment of myelodysplastic syndrome with low-dose human granulocyte colony-stimulating factor: A multicenter study
Published in International journal of hematology (01-08-2001)“…The objective of this study was to determine the hematopoietic effects and toxicity of low-dose granulocyte colony-stimulating factor (G-CSF) in…”
Get full text
Journal Article -
10
Endothelial activation and stress index as a prognostic factor of diffuse large B-cell lymphoma: the report from the nationwide multi-center Thai Lymphoma Study Group
Published in Annals of hematology (01-12-2023)“…Several prognostic models have been introduced to predict outcomes of patients with diffuse large B-cell lymphoma (DLBCL). Endothelial activation and stress…”
Get full text
Journal Article -
11
Impact of Early Switching to Nilotinib As Second Line TKI in Patients with Chronic Myeloid Leukemia Who Were Intolerant to, Suboptimal to and Failed Imatinib: The Thai Multi-Centered Study
Published in Blood (29-11-2018)“…Introduction: To date, the ELN recommendation and NCCN guidelines are the principle mile stones to follow up the treatment response and to make the decision of…”
Get full text
Journal Article -
12
The Expressions of P53, Bcl-2, and P-Glycoprotein and Prognostic Impact in Patients with Peripheral T-Cell Lymphoma (PTCL)
Published in Journal of the Medical Association of Thailand (01-10-2015)“…To define the expressions of p53, Bcl-2, and p-glycoprotein and prognostic impact in patients with peripheral T-cell lymphoma (PTCL). Adult patients with newly…”
Get more information
Journal Article -
13
EFS12 Is a Powerful Predictive Tool for Outcomes in Stage I Aggressive Non Hodgkin Lymphoma: A Report from Nationwide Registry in a Resource Limited Country Thai Lymphoma Study Group
Published in Blood (13-11-2019)“…Introduction: Stage I disease represents a minor subset of aggressive Non-Hodgkin Lymphoma (NHL) accounting around 10%. Overall prognosis is generally good but…”
Get full text
Journal Article -
14
A Matched-Pair Analysis of EPOCH Versus CHOP As Frontline Therapy for Nodal Peripheral T-Cell Lymphoma, Excluding ALK-Positive Anaplastic T-Cell Lymphoma: A Multicenter Experience in Thailand
Published in Blood (02-12-2016)“…BACKGROUND Nodal peripheral T-cell lymphomas (PTCLs), except ALK-positive anaplastic large cell lymphoma (ALCL) have inferior outcomes compared with their…”
Get full text
Journal Article -
15
Nilotinib As Second-Line Therapy in Patients with Chronic Myeloid Leukemia in Chronic Phase: Thailand Experience
Published in Blood (02-12-2016)“…Background: Nilotinib, a second generation tyrosine kinase inhibitor, was proved to have high efficacy on treatment of Philadelphia chromosome positive CML…”
Get full text
Journal Article -
16
Non‐Hodgkin lymphoma in South East Asia: An analysis of the histopathology, clinical features, and survival from Thailand
Published in Hematological oncology (01-02-2018)“…Systemic reports on the descriptive epidemiology of non‐Hodgkin lymphoma (NHL) from Southeast Asia are scarce. A nationwide multi‐institutional registry was…”
Get full text
Journal Article -
17
Event-free survival at 12 months is a strong surrogate endpoint for stage 1 diffuse large B cell lymphoma: a report from Nation Wide Registry Thai Lymphoma Study Group
Published in Leukemia & lymphoma (18-09-2020)“…Event-free survival at 12 months (EFS12) is a surrogate endpoint for long-term outcomes in many histologic lymphoma subtypes. However, most reports have…”
Get full text
Journal Article -
18
Event free survival at 24 months is a strong surrogate prognostic endpoint of peripheral T cell lymphoma
Published in Hematological oncology (01-12-2019)“…Event free survival at 24 months (EFS24) has been described as a powerful predictor for outcome in several subtypes of B cell lymphoma. However, it was…”
Get full text
Journal Article -
19
Clinical Features and Treatment Outcomes of Angioimmunoblastic T-Cell Lymphoma: An Analysis from a Nationwide Multicenter Registry, Thailand
Published in Blood (03-12-2015)“…To analyze clinical features, treatment outcomes in Thai patients with angioimmunoblastic T cell lymphoma (AITL). From a nationwide multicenter registry of…”
Get full text
Journal Article -
20
Mantle Cell Lymphoma, Rare Lymphoma Entity: A Result of Lymphoma Registry in Thailand
Published in Blood (03-12-2015)“…Introduction: Mantle cell lymphoma (MCL) is a relatively rare and aggressive mature B-cell non-Hodgkin lymphoma (NHL) entity, encounting for 3-10% of newly…”
Get full text
Journal Article